PubMed

Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes.

Petermeier K, Tatar O, Inhoffen W, Völker M, Lafaut BA, Henke-Fahle S, Gelisken F, Ziemssen F, Bopp S, Bartz-Schmidt KU, Grisanti S.

Br J Ophthalmol. 2006 Aug;90(8):1034-9. Epub 2006 Apr 13.PMID: 16613924 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.

Tatar O, Adam A, Shinoda K, Stalmans P, Eckardt C, Lüke M, Bartz-Schmidt KU, Grisanti S.

Am J Ophthalmol. 2006 Jul;142(1):95-104.PMID: 16815256 [PubMed - indexed for MEDLINE]Related articles

Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy.

Grisanti S, Tatar O, Canbek S, Lafaut BA, Gelisken F, Inhoffen W, Szurman P, Aisenbrey S, Oficjalska-Mlynczak J, Bartz-Schmidt KU.

Am J Ophthalmol. 2004 May;137(5):914-23.PMID: 15126158 [PubMed - indexed for MEDLINE]Related articles

Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.

Tatar O, Kaiserling E, Adam A, Gelisken F, Shinoda K, Völker M, Lafaut BA, Bartz-Schmidt KU, Grisanti S.

Arch Ophthalmol. 2006 Jun;124(6):815-23.PMID: 16769835 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration.

Tatar O, Adam A, Shinoda K, Yoeruek E, Szurman P, Bopp S, Eckardt C, Bartz-Schmidt KU, Grisanti S.

Retina. 2007 Jul-Aug;27(6):713-23.PMID: 17621180 [PubMed - indexed for MEDLINE]Related articles

Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.

Moshfeghi DM, Kaiser PK, Grossniklaus HE, Sternberg P Jr, Sears JE, Johnson MW, Ratliff N, Branco A, Blumenkranz MS, Lewis H.

Am J Ophthalmol. 2003 Mar;135(3):343-50.PMID: 12614752 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.

Tatar O, Adam A, Shinoda K, Eckert T, Scharioth GB, Klein M, Yoeruek E, Bartz-Schmidt KU, Grisanti S.

Br J Ophthalmol. 2007 Sep;91(9):1183-9. Epub 2007 May 2.PMID: 17475706 [PubMed - indexed for MEDLINE]Related articles

Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.

Tatar O, Shinoda K, Adam A, Eckert T, Eckardt C, Lucke K, Deuter C, Bartz-Schmidt KU, Grisanti S.

Br J Ophthalmol. 2007 Feb;91(2):166-73. Epub 2006 Sep 20.PMID: 16987895 [PubMed - indexed for MEDLINE]Related articles

Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.

Gelisken F, Lafaut BA, Inhoffen W, Voelker M, Grisanti S, Bartz-Schmidt KU.

Br J Ophthalmol. 2004 Feb;88(2):207-11.PMID: 14736776 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

[No authors listed]

Arch Ophthalmol. 1999 Oct;117(10):1329-45. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10532441 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.

Ladd BS, Solomon SD, Bressler NM, Bressler SB.

Am J Ophthalmol. 2001 Nov;132(5):659-67.PMID: 11704027 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.

Arch Ophthalmol. 1999 Sep;117(9):1161-73. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496388 [PubMed - indexed for MEDLINE]Related articles

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group.

Ophthalmology. 2009 Jan;116(1):57-65.e5.PMID: 19118696 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model.

Matsubara A, Nakazawa T, Noda K, She H, Connolly E, Young TA, Ogura Y, Gragoudas ES, Miller JW.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4741-7.PMID: 17898299 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

[Photodynamic therapy in age-related macular degeneration--results of one year observation]

Wykrota H, Gierek-Łapińska A.

Klin Oczna. 2002;104(3-4):239-43. Polish. PMID: 12608309 [PubMed - indexed for MEDLINE]Related articles

12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.

Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.

Retina. 2008 Feb;28(2):289-97.PMID: 18301052 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.

Ophthalmology. 2009 Apr;116(4):747-55, 755.e1. Epub 2009 Feb 25.PMID: 19243834 [PubMed - indexed for MEDLINE]Related articles